Announcement PDF Notification of buy-back Announcement Summary Name of entity ACTINOGEN MEDICAL LIMITED Announcement type New announcement Date of this announcement 27/9/2023 ASX Security code and description of the class of +securities the subject of the buy-back ACW : ORDINARY FULLY PAID The type of buy-back is: Employee share scheme buy-back Refer to next page for full details of the announcement Notification of buy-back 1/5 Notification of buy-back Part 1 - Entity and announcement details 1.1 Name of entity ACTINOGEN MEDICAL LIMITED We (the entity named above) provide the following information about our buy-back. 1.2 Registration number type Registration number ABN 14086778476 1.3 ASX issuer code ACW 1.4 The announcement is New announcement 1.5 Date of this announcement 27/9/2023 1.6 ASX Security code and description of the class of +securities the subject of the buy-back ACW : ORDINARY FULLY PAID Notification of buy-back 2/5 Notification of buy-back Part 2 - Type of buy-back 2.1 The type of buy-back is: Employee share scheme buy-back Notification of buy-back 3/5 Notification of buy-back Part 3 - Buy-back details Part 3A - Details of +securities, price and reason 3A.1 Total number of +securities on issue in the class of +securities to be bought back 2,216,310,088 3A.2 Total number of +securities proposed to be bought back 2,000,000 3A.9 Are the +securities being bought back for a cash consideration? No 3A.9b Please describe the consideration being provided to buy back the +securities Nil consideration Part 3B - Buy-back restrictions and conditions 3B.1 Does the buy-back require security holder approval? No 3B.3 Are there any other conditions that need to be satisfied before the buy-back offer becomes unconditional? No Notification of buy-back 4/5 Notification of buy-back Part 3C - Key dates Employee Share Scheme, Selective and Other Buy-Backs 3C.1 Anticipated date buy-back will occur 11/10/2023 Part 3D - Other Information 3D.1 Any other information the entity wishes to notify to ASX about the buy-back Nil Notification of buy-back 5/5